Method to detect β2 adrenergic receptor-βarrestin2 Interactions to accelerate drug discovery
This invention relates to the development of a novel platform to accurately monitor β2 adrenergic receptor (a prototypical GPCR) and β-arrestin2 (i.e., intracellular binding protein and signaling mediator) interactions in real-time living systems.
Patents
  • Provisional Patent Application Filed, 63/022,672
Case ID
2020-038
Inventor
Bradley McConnell
Associate Professor, Pharmacological & Pharmaceutical Sciences
Category